Arcellx (ACLX) announced that it will present clinical data in a poster presentation from its Phase 1 study of anitocabtagene autoleucel in ...

NEWARK, CA / ACCESSWIRE / November 5, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that final data from the Phase 2 REVIVE study with rusfertide in polycythemia ...

Descartes-08, Cartesian’s lead mRNA cell therapy candidate, is an autologous mRNA-engineered chimeric antigen receptor T-cell therapy (mRNA CAR-T) product candidate targeting B-cell maturation antigen ...

About PYRUKYND® (mitapivat) PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency in the United States, and for the ...

PharmaJet Poster Presentation at Cancer Immunotherapy Conference Highlights How Needle-free Technology is Enhancing Oncology ...

(NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across a range of B-cell malignancies and assets, including best-in-class Bruton’s tyrosine ...

Oftentimes, campaign posters were the only way voters saw the faces of political candidates. All of the seats were filled at ...

Michelle Hilaire, interim dean of the College of Health Sciences, says the staff was proud of the UW WWAMI medical students’ ...

Students are strongly encouraged to bring copies of their resumes/CVs. The graduate school fair hosted by FURC is an excellent way to network with many universities across the country. Over 30 ...

Viking Therapeutics highlights VK2735's promising weight loss data at ObesityWeek 2024, with up to 14.7% reduction and ...